GABRIELLA REED: Open Payments
NPI 1992247589 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 48 payments from 12 companies in 2025. Trend: 2023 $69 · 2024 $1,031 · 2025 $1,171
Food & beverage: $1,171
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 20 | $410 |
| Organon LLC | 8 | $229 |
| GENZYME CORPORATION | 5 | $137 |
| ABBVIE INC. | 4 | $101 |
| Janssen Biotech, Inc. | 1 | $86 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $78 |
| Lilly USA, LLC | 2 | $34 |
| LEO Pharma Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: Bimzelx, DUPIXENT, VTAMA, TREMFYA, SKYRIZI, ILUMYA, TALTZ, RINVOQ.
Industry payments across VA — which companies pay providers there.
